KBE vs XLV
SPDR S&P Bank ETF vs Health Care Select Sector SPDR Fund
- • XLV has the lower expense ratio at 0.08% vs 0.35% for KBE.
- • KBE pays a higher dividend yield (2.24%).
Side-by-side metrics
| Metric | KBE | XLV |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.35% | 0.08% |
Dividend yield Trailing 12-month yield. | 2.24% | 1.38% |
AUM Assets under management — bigger funds are typically more liquid. | $1.50B | $49.10B |
YTD return | 12.47% | 23.16% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.97 | 0.41 |
P/E ratio | 12.41 | 30.63 |
Last price | $66.56 | $187.94 |
Inception | — | — |
Issuer | State Street | State Street |
KBE top holdings
| CBC | Central Bancompany Inc Class A | 1.07% |
| FCNCA | First Citizens BancShares Inc Class A | 1.06% |
| CUBI | Customers Bancorp Inc | 1.03% |
| GBCI | Glacier Bancorp Inc | 1.02% |
| CATY | Cathay General Bancorp | 1.01% |
| UCB | United Community Banks Inc | 1.00% |
| TCBI | Texas Capital Bancshares Inc | 1.00% |
| OZK | Bank OZK | 1.00% |
| EQH | Equitable Holdings Inc | 0.99% |
| EBC | Eastern Bankshares Inc Ordinary Shares | 0.99% |
XLV top holdings
| LLY | Eli Lilly and Co | 16.88% |
| JNJ | Johnson & Johnson | 9.80% |
| ABBV | AbbVie Inc | 7.76% |
| MRK | Merck & Co Inc | 5.49% |
| UNH | UnitedHealth Group Inc | 5.44% |
| TMO | Thermo Fisher Scientific Inc | 3.84% |
| AMGN | Amgen Inc | 3.75% |
| GILD | Gilead Sciences Inc | 3.15% |
| ABT | Abbott Laboratories | 2.74% |
| PFE | Pfizer Inc | 2.59% |
About KBE
KBE (SPDR S&P Bank ETF) is US banking industry stocks, broad coverage. Managed by State Street, the fund carries $1.5B in assets under management, an expense ratio of 0.35%, a dividend yield of 2.24%. Its largest holding is Central Bancompany Inc Class A (CBC), which represents 1.1% of the portfolio. Financial Services is the fund's largest sector exposure at 100.0%.
About XLV
XLV (Health Care Select Sector SPDR Fund) is S&P 500 health care sector. Managed by State Street, the fund carries $49.1B in assets under management, an expense ratio of 0.08%, a dividend yield of 1.38%. Its largest holding is Eli Lilly and Co (LLY), which represents 16.9% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.